APA (7th ed.) Citation

Pin Zhang, Binghe Xu, Lin Gui, Wenna Wang, Meng Xiu, Xiao Zhang, . . . Jianjun Zou. (2021). A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer. BMC.

Chicago Style (17th ed.) Citation

Pin Zhang, Binghe Xu, Lin Gui, Wenna Wang, Meng Xiu, Xiao Zhang, Guilan Sun, Xiaoyu Zhu, and Jianjun Zou. A Phase 1 Study of Dalpiciclib, a Cyclin-dependent Kinase 4/6 Inhibitor in Chinese Patients with Advanced Breast Cancer. BMC, 2021.

MLA (9th ed.) Citation

Pin Zhang, et al. A Phase 1 Study of Dalpiciclib, a Cyclin-dependent Kinase 4/6 Inhibitor in Chinese Patients with Advanced Breast Cancer. BMC, 2021.